A meta-analysis of cytokines in Alzheimer's disease
- PMID: 20692646
- DOI: 10.1016/j.biopsych.2010.06.012
A meta-analysis of cytokines in Alzheimer's disease
Abstract
Background: Studies suggest that inflammation is involved in the neurodegenerative cascade leading to Alzheimer's disease (AD) pathology and symptoms. This study sought to quantitatively summarize the clinical cytokine data.
Methods: Original English language peer-reviewed studies measuring cytokine concentrations in AD and healthy control subjects were included. Mean (± standard deviation) cytokine concentrations for AD and control subjects were extracted.
Results: Forty studies measuring peripheral blood cytokine concentrations and 14 measuring cerebrospinal fluid (CSF) cytokine concentrations were included. In peripheral blood, there were significantly higher concentrations (weighted mean difference [95% confidence interval]) of interleukin (IL)-6 (2.86 [1.68, 4.04] pg/mL, p < .00001, N[AD/control subjects] = 985/680, 14 studies), tumor necrosis factor (TNF)-α (3.25 [.76, 5.74] pg/mL, p = .01, N = 680/447, 14 studies), IL-1β (.55 [.32, .78] pg/mL, p < .00001, N = 574/370, 10 studies), transforming growth factor (TGF)-β (67.23 [28.62, 105.83] pg/mL, p = .0006, N = 190/158, 5 studies), IL-12 (7.60 [5.58, 9.62] pg/mL, p < .00001, N = 148/106, 5 studies), and IL-18 (15.82 [1.98, 29.66] pg/mL, p = .03, N = 131/94, 4 studies) but not of IL-4, IL-8, IL-10, interferon-γ, or C-reactive protein in AD subjects compared with control subjects. There were significantly higher concentrations of TGF-β (7.81 [2.27, 13.35] pg/mL, p =.006, N = 113/114, 5 studies) but not IL-6, TNF-α, and IL-1β in the CSF of AD subjects compared with control subjects.
Conclusions: These results strengthen the clinical evidence that AD is accompanied by an inflammatory response, particularly higher peripheral concentrations of IL-6, TNF-α, IL-1β, TGF-β, IL-12 and IL-18 and higher CSF concentrations of TGF-β.
Copyright © 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Peripheral cytokines and chemokines in Alzheimer's disease.Dement Geriatr Cogn Disord. 2009;28(4):281-7. doi: 10.1159/000245156. Epub 2009 Oct 10. Dement Geriatr Cogn Disord. 2009. PMID: 19828948 Review.
-
Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies.J Alzheimers Dis. 2012;30(4):981-4. doi: 10.3233/JAD-2012-120244. J Alzheimers Dis. 2012. PMID: 22475798 Review.
-
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.Dement Geriatr Cogn Disord. 2009;27(5):481-90. doi: 10.1159/000218081. Epub 2009 May 12. Dement Geriatr Cogn Disord. 2009. PMID: 19439966 Clinical Trial.
-
Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.Front Immunol. 2018 Sep 19;9:2122. doi: 10.3389/fimmu.2018.02122. eCollection 2018. Front Immunol. 2018. PMID: 30283455 Free PMC article.
-
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.Methods. 2012 Apr;56(4):508-13. doi: 10.1016/j.ymeth.2012.03.017. Epub 2012 Mar 24. Methods. 2012. PMID: 22465283 Review.
Cited by
-
Variant-to-function mapping of late-onset Alzheimer's disease GWAS signals in human microglial cell models implicates RTFDC1 at the CASS4 locus.bioRxiv [Preprint]. 2024 Aug 22:2024.08.22.609230. doi: 10.1101/2024.08.22.609230. bioRxiv. 2024. PMID: 39229212 Free PMC article. Preprint.
-
Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.Neurodegener Dis Manag. 2016 Jun;6(3):203-13. doi: 10.2217/nmt-2015-0009. Epub 2016 May 27. Neurodegener Dis Manag. 2016. PMID: 27229914 Free PMC article.
-
Relationships among tumor necrosis factor-alpha levels, beta-amyloid accumulation, and hippocampal atrophy in patients with late-life major depressive disorder.Brain Behav. 2024 Sep;14(9):e70016. doi: 10.1002/brb3.70016. Brain Behav. 2024. PMID: 39236111 Free PMC article.
-
Caveolae, CD109, and endothelial cells as targets for treating Alzheimer's disease.Alzheimers Dement (N Y). 2020 Sep 13;6(1):e12066. doi: 10.1002/trc2.12066. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 32995471 Free PMC article.
-
Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.Aging Dis. 2015 Aug 1;6(4):282-99. doi: 10.14336/AD.2014.002. eCollection 2015 Aug. Aging Dis. 2015. PMID: 26236550 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous